The aim of the study is to study the utility of various inflammatory markers in predicting outcomes of hospitalized patients with coronavirus disease 2019 (COVID-19) pneumonia.

Matéria original

Anterior

Chamada Pública Nº 011 /2021

Próxima

GalNAc-siRNA conjugates: Prospective tools on the frontier of anti-viral therapeutics